Prussian blue-inspired constructs for multimodal imaging and therapy

Patent metadata

Field	Value
Publication number	US-9987378-B2
Application number	US-201615390106-A
Country	US
Kind code	B2
Filing date	Dec 23, 2016
Priority date	Mar 15, 2013
Publication date	Jun 5, 2018
Grant date	Jun 5, 2018

Abstract

The invention describes a coordination polymer construct for multimodal imaging and therapy. The construct consists of a core particle made of a novel coordination polymer. The core is coated with a biocompatible coating that stabilizes the particles in a physiological environment. The biocompatible coating can contain attached targeting agents, imaging agents and therapeutic agents or combinations one or more of the targeting, imaging and therapeutic agents. When administered to a subject or a subject-derived specimen, the resulting coordination polymer core-shell construct enables multimodal imaging and therapy, which improves the diagnostic and treatment outcomes of the conditions or diseases where it is administered. The invention describes the novel material, base for the construct, methods for the preparation of the said construct and its use as a multimodal imaging and therapy agent.

First claim

We claim:

1. A composition, comprising a core of doped Prussian blue analog lattice compound comprising interstitial cations and a shell of biocompatible coating modified with a fluorophore, a contrast agent, a targeting agent, a therapeutic agent, or any combination thereof; wherein said doped Prussian blue analog lattice compound is represented by general formula (I):
A x B y M 4 [M′(CN) 6 ] z .n H 2 O  (I)

wherein:
x is from 0.1 to 1;
y is from 0.1 to 1;
z is from 0.1 to 4; and
n is from 0.1 to 24;
wherein the Prussian blue analog lattice compound is represented by general formula (I) comprising (i) A is selected from the group consisting of at least one of K, Gd, Mn and Fe; B is a mixture of Mn and Gd, and M and M′ are selected from the group consisting of at least one of K, Gd, Mn and Fe; and/or (ii) wherein A is selected from the group consisting of at least one of Li, Na, K, Rb, Cs, and Fr; B is a mixture of Mn and Gd, and M and M′ are selected from the group consisting of at least one of Fe, Co, and Ni or mixtures thereof; and/or (iii) wherein A is K and B is a mixture of Mn and Gd, and wherein M and M′ are Fe.

2. The composition of claim 1 , wherein said doped Prussian blue analog lattice compound has a particle size of about 1 nanometer to about 10 microns.

3. The composition according to claim 1 , wherein said biocompatible coating stabilizes the composition against aggregation, serve as a platform for attachment of molecules or metals, and prevent leakage of ions from the core to the surrounding.

4. The composition according to claim 1 in a form suitable for medical radiography, magnetic resonance imaging, scintigraphy, single-photon emission computed tomography, positron emission tomography, photoacoustic imaging, ultrasound, optical fluorescence imaging, optical bioluminescence imaging, surface enhanced Raman scattering imaging, intravital microscopy, or any combination thereof.

5. The composition according to claim 1 , wherein said biocompatible coating is in contact with the core by physical or chemical interactions between the biocompatible coating and the core.

6. The composition according to claim 5 , wherein said physical or chemical interactions are electrostatic interactions, covalent interactions, hydrophobic interactions, van dew Waal's interactions, or any combination thereof.

7. An imaging agent comprising the composition according to claim 1 .

8. A therapeutic agent comprising the composition according to claim 1 , wherein said contrast agent, targeting agent, or therapeutic agent is present in said photothermally responsive material and has a wavelength absorbance maximum of about 600 nm to 1200 nm.

9. A therapeutic agent comprising the composition according to claim 1 , a peptide and fluorophore for imaging protease expressed in cell and in tissue.

10. The composition according to claim 1 , by which a quenching effect is generated with the fluorophore on the surface thereof.

11. A method for detecting a target associated with a disorder or disease, comprising contacting the target with a composition according to claim 1 that interacts with the target, and imaging and detecting the target.

12. The method of claim 11 , wherein the target is a cancer cell in a patient and the composition interacts with the cancer cell, thereby imaging and detecting the cancer cell.

13. The composition of claim 1 , wherein x, y and z each range from 0.5 to 0.6.

Assignees

• Childrens Nat Medical Ct

Inventors

• Fernandes Rohan
• Dumont Matthieu F
• Sze Raymond W
• Conklin Laurie S
• Hoffman Hilary A
• Jaiswal Jyoti K

Classifications

• A61K9/143

  with inorganic compounds · CPC title

• A61K49/0032 Primary

  Methine dyes, e.g. cyanine dyes · CPC title

• A61K49/0017

  Fluorescence in vivo · CPC title

• A61K47/6923

  the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb · CPC title

• A61K41/0052

  Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy · CPC title